These results confirm that without the survivin epitope, the adaptive immune response does not occur properly, and the lipid membrane of the nano‐assembly provides stability in the body, enhancing the ability to deliver adjuvants and the survivin peptide epitope to dendritic cells, resulting in effective anti‐tumor effects. The gene discussed is BIRC5; the disease is neoplasm.